This investment was made under a previous strategy. We disclose information on all our current investments, but narrative information on our pre-2012 investments, when we introduced a new strategy, may be limited.
ReaMetrix is an early stage company working on a high end diagnostic solution called Flow Cytometer. The re-engineered solution will facilitate access to diagnostic tests done on this device in India and other emerging markets where majority of the patient population cannot afford them presently.
Since 2012, we’ve only invested in Africa and South Asia. Investments outside these regions are from our pre-2012 portfolio.
- South Asia
We have seven priority sectors. However, we continue to invest outside these sectors, largely in the most challenging regions, as new investment supporting any sector helps to underpin the private sector, and create jobs and livelihoods for people.
- Investment type
We provide capital in three broad ways: direct equity, debt, and intermediated equity (principally through investment funds).
- Intermediated investment
- Baring India Private Equity Fund II LP
- Fund Manager:
- Baring Private Equity Partners India
- Start date
For direct investments, this is the date CDC committed capital to the business or project.
For funds, this is the date that CDC committed capital to the fund.
For underlying fund investments, this is the date that the fund invested capital into the business.e
- June 2007
This is the investee company’s place of incorporation; or a fund’s jurisdiction.